SCHEMBL4313841

SCHEMBL4313841

Cc1ccccc1C(=O)Nc1ccccc1/C=C/c1n[nH]c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TP53 P04637 1/20 0.46
CTNNB1 P35222 1/20 0.46
WNT3A P56704 1/20 0.46
CSF1R P07333 1/20 0.45
KDR P35968 2/20 0.45
EPHB3 P54753 1/20 0.44
ALPL P05186 1/20 0.43
AURKA O14965 2/20 0.42
SLC16A3 O15427 1/20 0.41
AURKB Q96GD4 1/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4313848 1.00 PARP1 (0.46) PARP1ALDH1A1L3MBTL1TP53CTNNB1
SCHEMBL4308176 0.86 KDR (0.46) L3MBTL1TP53CTNNB1WNT3AKDR
SCHEMBL4308171 0.86 KDR (0.46) L3MBTL1TP53CTNNB1WNT3AKDR
SCHEMBL4314057 0.86 CSF1R (0.46) TP53CSF1RKDREPHB3AURKA
SCHEMBL4314067 0.86 CSF1R (0.46) TP53CSF1RKDREPHB3AURKA
SCHEMBL4314383 0.86 MEN1 (0.50) ALDH1A1L3MBTL1TP53CTNNB1WNT3A
SCHEMBL4314378 0.86 MEN1 (0.50) ALDH1A1L3MBTL1TP53CTNNB1WNT3A
SCHEMBL4312091 0.85 KDR (0.53) PARP1CSF1RKDREPHB3AURKA
SCHEMBL4312084 0.85 KDR (0.53) PARP1CSF1RKDREPHB3AURKA
SCHEMBL4315179 0.85 KDR (0.59) KDREPHB3FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 PARP1 3697/4885ALDH1A1 1250/4885L3MBTL1 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.